Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/12 → 31/12/15 |
Funding
- NHMRC - National Health and Medical Research Council (Australia): A$391,076.00
-
A comparison of the pharmacokinetics and pulmonary lymphatic exposure of a generation 4 PEGylated dendrimer following intravenous and aerosol administration to rats and sheep
Ryan, G., Bischof, R., Enkhbaatar, P., McLeod, V. M., Chan, L. J., Jones, S. A., Owen, D. J., Porter, C. J. & Kaminskas, L. M., 2016, In: Pharmaceutical Research. 33, 2, p. 510-525 16 p.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile22 Link opens in a new tab Citations (Scopus) -
Conjugation of 10 kDa linear PEG onto trastuzumab Fab′ is sufficient to significantly enhance lymphatic exposure while preserving in vitro biological activity
Chan, L., Ascher, D. B., Yadav, R., Bulitta, J., Williams, C. C., Porter, C., Landersdorfer, C. & Kaminskas, L., 2016, In: Molecular Pharmaceutics. 13, 4, p. 1229-1241 13 p.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile26 Link opens in a new tab Citations (Scopus) -
Designing a multi-component spray-dried formulation platform for pulmonary delivery of biopharmaceuticals: the use of polyol, disaccharide, polysaccharide and synthetic polymer to modify solid-state properties for glassy stabilisation
Sou, T., Forbes, R. T., Gray, J., Prankerd, R. J., Kaminskas, L. M., McIntosh, M. P. & Morton, D. A. V., 1 Jan 2016, In: Powder Technology. 287, p. 248-255 8 p.Research output: Contribution to journal › Article › Research › peer-review
22 Link opens in a new tab Citations (Scopus)